Using the air pouch model for assessing in vivo inflammatory activity of nanoparticles
Authors Girard D
Received 23 December 2013
Accepted for publication 27 December 2013
Published 24 February 2014 Volume 2014:9(1) Pages 1105—1109
Checked for plagiarism Yes
INRS – Institut Armand-Frappier/Université du Québec, Québec, QC, Canada
I would like to make some comments and clarifications regarding the article "Intradermal air pouch leukocytosis as an in vivo test for nanoparticles" recently published in the International Journal of Nanomedicine. In this study, Vandooren et al1 used the air pouch model for evaluating potential pro-inflammatory effects of nanoparticles (NPs). This model is certainly suitable for investigating the inflammatory process which occurs during sterile inflammation and is suitable for determining if an agent, including a given NP, possesses pro-inflammatory activity or not.
View original paper by Vandooren and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]